Compound class:
Synthetic organic
Comment: Aberrant activation of matrix metalloproteinase 13 (MMP13), whose substrate is fibrillar collagen, in atherosclerotic plaques is associated with the progression of unstable atherosclerosis [2-4]. This fluorine-18 labelled MMP13 inhibitor can be used to visualise MMP13 within atherosclerotic plaques [1].
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Collagenase MMP8 and stromelysin MMP10 are the primary off-targets for this inhibitor. |
Selectivity at enzymes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|